This observation is consistent with previous studies indicating that SCUBE2 expression is associated with chemotherapy resistance and may influence clinical outcomes in breast cancer[38, 39] Pathway enrichment analysis further revealed that these gene expression differences were associated with immune‐related biological processes, including immune response regulation, antigen presentation, and cell adhesion. This evidence concerns the gene SCUBE2 and breast cancer.